Support

2024 – 2026
Bioorthogonal reactions of 1-alkyl-1,2,4-triazinium salts
Czech Science Foundation, Grant Nr. 24-10829S

2024–2028
New Technologies for Translational Research in Pharmaceutical Sciences / NETPHARM
Programme Johannes Amos Comenius, Ministry of Education Youth and Sports, co-funded by EU

2023–2028
Development of chimeric antigen receptor modified immune cells for cancer immunotherapy
Personalized Medicine: From Translational Research to Biomedical Applications (PerMed:T2BA)
Technology Agency of the Czech Republic as part of the National Centers of Competence Program

2022–2024
CHEMCELL: Chemical Engineering of Natural Killer Cells for Cancer Immunotherapy
European Research Council ERC Proof of Concept Grant, Project Nr. 101081736

2022–2025
Characterization of the significance of novel lipid signaling molecules for sensitivity to insulin
National Institute for Research of Metabolic and Cardiovascular Diseases
Funded by the European Union – Next Generation EU, Program EXCELES - CarDia, Project Nr. LX22NPO5104

2020–2023
Bioorthogonal time-controlled intramitochondrial elimination
Czech Science Foundation, GF20-30494L

2019–2022
Construction of synthetic scaffolds enabling subcellular organelle-specific release chemistry
Czech Science Foundation, P207/19-13811S

2017–2021
GSRS – Gilead Sciences and IOCB Research Centre
Supported by Gilead Sciences, Inc.

2016–2021
SWEETOOLS: Smart Biologics: Developing New Tools In Glycobiology
European Research Council Starting Grant: ERC-2015-StG (No. 677465)

2015–2018
Development of new bioorthogonal reactions
Czech Science Foundation, P207/15-06020Y